- Home
- Labeler Index
- Glaxosmithkline Biologicals Sa
- 58160-909
- NDC Crossover: 58160-909 Fluarix Quadrivalent 2023/2024
NDC Crossover 58160-909 Fluarix Quadrivalent 2023/2024
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Influenza A Virus A/darwin/6/2021 Ivr-227 (h3n2) Antigen (formaldehyde Inactivated); Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated); Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated)
Explore similar products and medications to NDC 58160-909 Fluarix Quadrivalent 2023/2024 a vaccine label with other products crossover matching the same product name (Fluarix Quadrivalent 2023/2024) or generic name (Influenza Virus Vaccine), and the same administration route (intramuscular) or dosage form (suspension). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 33332-323 | Afluria Quadrivalent | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/darwin/6/2021 Ivr-227 (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated), Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Pty Ltd. | Vaccine |
| 33332-423 | Afluria Quadrivalent | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/darwin/6/2021 Ivr-227 (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated), Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Pty Ltd. | Vaccine |
| 70461-123 | Fluad Quadrivalent | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/6/2021 Ivr-227 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Seqirus, Inc. | Vaccine |